Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline

benzinga.com/markets/earnings/25/07/46554815/danaher-lifts-2025-earnings-outlook-amid-biotech-growth-cost-discipline

Danaher Corp (NYSE:DHR) on Tuesday reported second-quarter 2025 sales of $5.94 billion, up 3.5% year-over-year, beating the consensus of $5.84 billion.
The life science giant reported adjusted earnings of $1.80 per share, beating the consensus of $1.64.
Non-GAAP core revenue increased…

This story appeared on benzinga.com, 2025-07-22 18:05:20.
The Entire Business World on a Single Page. Free to Use →